BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 23229926)

  • 1. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2.
    Hwang HS; Yang KJ; Park KC; Choi HS; Kim SH; Hong SY; Jeon BH; Chang YK; Park CW; Kim SY; Lee SJ; Yang CW
    Nephrol Dial Transplant; 2013 May; 28(5):1156-66. PubMed ID: 23229926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E
    Hong YA; Yang KJ; Jung SY; Park KC; Choi H; Oh JM; Lee SJ; Chang YK; Park CW; Yang CW; Kim SY; Hwang HS
    Oxid Med Cell Longev; 2017; 2017():5031926. PubMed ID: 28465762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction.
    Zhu JX; Kalbfleisch M; Yang YX; Bihari R; Lobb I; Davison M; Mok A; Cepinskas G; Lawendy AR; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1218-27. PubMed ID: 23046222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury.
    Lee JW; Kim SC; Ko YS; Lee HY; Cho E; Kim MG; Jo SK; Cho WY; Kim HK
    Biochem Biophys Res Commun; 2014 Feb; 444(2):121-7. PubMed ID: 24434153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
    Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
    Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury.
    Feitoza CQ; Câmara NO; Pinheiro HS; Gonçalves GM; Cenedeze MA; Pacheco-Silva A; Santos OF
    Int Immunopharmacol; 2005 Jan; 5(1):79-84. PubMed ID: 15589463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
    Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
    Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of clusterin expression worsens renal ischemia-reperfusion injury.
    Zhou W; Guan Q; Kwan CC; Chen H; Gleave ME; Nguan CY; Du C
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F568-78. PubMed ID: 20007348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury.
    Liu M; Agreda P; Crow M; Racusen L; Rabb H
    Transplant Proc; 2009 Dec; 41(10):4065-71. PubMed ID: 20005342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
    Huber JM; Tagwerker A; Heininger D; Mayer G; Rosenkranz AR; Eller K
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F451-60. PubMed ID: 19458122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Powerful protection against renal ischemia reperfusion injury by T cell-specific NF-κB inhibition.
    Xue C; Liu Y; Li C; Li Y; Yang T; Xie L; Zhou P
    Transplantation; 2014 Feb; 97(4):391-6. PubMed ID: 24398854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injury
.
    Ersan S; Celik A; Tanrisev M; Kose I; Cavdar Z; Unlu M; Kocak A; Ural C; Yilmaz B; Kose T
    Clin Nephrol; 2017 Nov; 88(11):231-238. PubMed ID: 28737133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury.
    Hou J; Cai S; Kitajima Y; Fujino M; Ito H; Takahashi K; Abe F; Tanaka T; Ding Q; Li XK
    Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1149-57. PubMed ID: 23904222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.
    Park JW; Bae EH; Kim IJ; Ma SK; Choi C; Lee J; Kim SW
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F301-13. PubMed ID: 19940033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
    Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury.
    Zahedi K; Wang Z; Barone S; Prada AE; Kelly CN; Casero RA; Yokota N; Porter CW; Rabb H; Soleimani M
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1046-55. PubMed ID: 12554636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice.
    Hu H; Zou C; Xi X; Shi Z; Wang G; Huang X
    J Surg Res; 2012 Nov; 178(1):460-5. PubMed ID: 22507688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
    Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury.
    Cau J; Favreau F; Zhang K; Febrer G; de la Motte GR; Ricco JB; Goujon JM; Hauet T
    J Vasc Surg; 2009 Mar; 49(3):728-40. PubMed ID: 19268775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
    Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T
    J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.